ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Pivotal Analytics Announces $10.2 Million Series A Funding Round

Strategic healthcare analytics platform Pivotal plans to invest in key talent and enhancement of product offerings

Pivotal
Pivotal

Pivotal logo

WASHINGTON - October 7, 2021 - (Newswire.com)

Pivotal Analytics, the creator of strategic healthcare analytics solution Pivotal, announced it completed a $10.2 million Series A funding round. This investment was led by one of the largest owner-operators of medical office buildings in the United States, with participation from three existing investors.

Pivotal, the company's flagship business intelligence platform, is a strategic healthcare analytics solution that empowers healthcare organizations, developers, REITs, consultants, and other healthcare facility experts to better predict care supply and demand in specific target markets. By combining deep healthcare knowledge, top-tier data sets, and a powerful analytics engine, Pivotal translates raw, objective data into meaningful information that fuels any healthcare system planning scenario. The result is a much more precise and timely understanding of unmet care needs, now and in the future, and the ability to dynamically project the facility and talent resources necessary to meet those needs.

"It's extremely validating to have industry leaders recognize the value of our platform," said Carl Davis, CEO and Co-Founder of Pivotal Analytics.

"Pivotal integrates specialized healthcare and real estate data in unique ways to deliver strategic insights and a better perspective for healthcare opportunities," said Carl Davis, CEO and co-founder of Pivotal Analytics. "It's extremely validating to have industry leaders recognize the value of our platform, and we are thrilled to benefit from their advice and experience as we help our customers make better real estate and operational decisions."

"In addition, we can't emphasize enough how important it is to us that Pivotal customers were major contributors to this round," said Fady Barmada, President and co-founder of Pivotal Analytics. "It means so much to know the users and buyers of our solutions are also willing to invest resources and time to help us bring the Pivotal vision to market faster."

Pivotal Analytics plans to use the capital to support product enhancements which include growing its library of top-tier data partners and proprietary algorithms and redesigning the user experience to support different user types. Additionally, the newly secured funding will help scale up talent and tools in areas needed for growth, including product development and engineering.

About Pivotal Analytics

Pivotal Analytics is an information technology and services company that gives health systems the strategic market intelligence required to create the spaces they need to provide the best care possible. By mapping patient behavior with hospital throughput, we can help health organizations spot "healthcare deserts" and allocate resources proactively. Visit us at pivotal-analytics.com and on LinkedIn.

Media Contact:
Sylvia Marten
Pivotal Analytics
(312) 259-6252
smarten@pivotal-analytics.com




Press Release Service by Newswire.com

Original Source: Pivotal Analytics Announces $10.2 Million Series A Funding Round
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.